MAPT and Alzheimer disease: Of the 52 living biopsies, Aβ plaques were identified in 19 subjects, Aβ plaques and phosphorylated tau pathology in eight subjects, and no pathology in the remaining 25 subjects; for subjects with Aβ pathology, the subsequent onset of AD was determined in longitudinal studies.